Deccan Health Care (BOM:542248) ROIC %: 1.49% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542248 Deccan Health Care Ltd BOM:542248
78 GF Score
Price ₹12.99
GF Value ₹26.18
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Deccan Health Care ROIC %?

Deccan Health Care BOM:542248 -0.08% 78 ROIC % is 1.49% as of Mar. 2026. GuruFocus rates BOM:542248 with a GF Score™ of 78/100 and a GF Value™ of ₹26.18 (Significantly Undervalued). The stock has 6 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Deccan Health Care's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was 1.49%.

As of today (2026-07-17), Deccan Health Care's WACC % is 24.72%. Deccan Health Care's ROIC % is 2.34% (calculated using TTM income statement data). Deccan Health Care earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Deccan Health Care  (BOM:542248) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Deccan Health Care's WACC % is 24.72%. Deccan Health Care's ROIC % is 2.34% (calculated using TTM income statement data). Deccan Health Care earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Deccan Health Care ROIC % Related Terms


Deccan Health Care ROIC % Historical Data

* Premium members only.

The historical data trend for Deccan Health Care's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Deccan Health Care ROIC % Chart

Deccan Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.01 0.50 1.65 1.13 2.33

Deccan Health Care Quarterly Data
Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.87 3.51 3.51 1.49

BOM:542248 vs ZTS, UTHR: ROIC % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deccan Health Care ROIC % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's ROIC % distribution charts can be found below:

* The bar in red indicates where Deccan Health Care's ROIC % falls into.


BOM:542248
78GF Score
Deccan Health Care Ltd BOM:542248
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Deccan Health Care ROIC % Calculation

Deccan Health Care's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROIC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=36.233 * ( 1 - 23.83% )/( (1123.001 + 1244.049)/ 2 )
=27.5986761/1183.525
=2.33 %

where

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1249.271 - 90.731 - ( 35.539 - max(0, 156.97 - 1062.417+35.539))
=1123.001

Invested Capital(A: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1489.089 - 220.529 - ( 24.511 - max(0, 340.474 - 1297.308+24.511))
=1244.049

Deccan Health Care's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2026 is calculated as:

ROIC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=20.38 * ( 1 - 8.99% )/( (0 + 1244.049)/ 1 )
=18.547838/1244.049
=1.49 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1489.089 - 220.529 - ( 24.511 - max(0, 340.474 - 1297.308+24.511))
=1244.049

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 1.49% mean?
Deccan Health Care (BOM:542248) has a ROIC % of 1.49% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Deccan Health Care and its competitors.
Is Deccan Health Care's ROIC % too high?
Deccan Health Care's current ROIC % is 1.49%. The Drug Manufacturers industry median ROIC % is 4.46. Deccan Health Care's value of 1.49% is 66.6% below this industry median. Overall, Deccan Health Care has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deccan Health Care's ROIC % compare to ZTS and UTHR?
Deccan Health Care's ROIC % of 1.49% can be compared against companies in the Drug Manufacturers industry. The industry median ROIC % is 4.46. Deccan Health Care's value of 1.49% is 66.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Drug Manufacturers company?
The median ROIC % among Drug Manufacturers companies is 4.46, based on 990 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deccan Health Care's current ROIC % of 1.49% is 66.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Deccan Health Care and its competitors. For the Drug Manufacturers industry, the median ROIC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deccan Health Care's current ROIC % is 1.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deccan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Deccan Health Care (BOM:542248) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹26.18, compared to a current price of ₹12.99 — trading 50.4% below its estimated fair value. The current ROIC % is 1.49% and 66.6% below the Drug Manufacturers industry median of 4.46. Deccan Health Care's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Deccan Health Care (BOM:542248), the current ROIC % is 1.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Deccan Health Care (BOM:542248) Overvalued in 2026?

Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued. The current stock price of ₹12.99 is trading 50.4% below its estimated GF Value™ of ₹26.18. GuruFocus considers Deccan Health Care to be Significantly Undervalued.

Key valuation signals for BOM:542248:

  • ROIC %: 1.49%
  • GF Value™: ₹26.18 vs. price of ₹12.99 (50.4% below fair value)
  • GF Score™: 78/100 with 6 warning signs
  • Industry Position: 66.6% below the Drug Manufacturers median

No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Deccan Health Care Business Description

Address 6-3-347/17/5/A/Back Position, Dwarakapuri Colony, Punjagutta, Hyderabad, TG, IND, 500082
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
78GF Score

Get the complete analysis for BOM:542248

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹12.99
Price
₹26.18
GF Value